Posted On: 10/22/2013 7:43:17 PM
Post# of 63750
Re: Shalom Star #17243
- Merck Receives Breakthrough Therapy Designation for MK-5172/MK-8742, an Investigational Oral Combination Regimen for the Treatment of Chronic Hepatitis C Virus (HCV) Infection
5:00 pm - Business Wire
(0)
(0)Scroll down for more posts ▼
